Christopher Ehrlich

Christopher Ehrlich

Director/Board Member en EFFECTOR THERAPEUTICS, INC. .

Fortuna: 2 M $ al 31/03/2024

54 años
Health Technology
Finance
Consumer Services

Perfil

Christopher B.
Ehrlich
is the founder of Prostate Management Diagnostics, Inc. (founded in 2014) and holds the title of Director.
He is also the founder of AlgoRx Pharmaceuticals, Inc. Mr. Ehrlich's current jobs include being a Director at QuatRx Pharmaceuticals Co. (since 2004), Prolynx LLC (since 2022), and eFFECTOR Therapeutics, Inc. (since 2021).
He is also the Chief Operating Officer & Director at CERo Therapeutics Holdings, Inc. (since 2021).
Mr. Ehrlich's former jobs include being the Chief Executive Officer & Director at Locust Walk Acquisition Corp.
(2020-2021), Chief Executive Officer & Director at Phoenix Biotech Acquisition Corp., Director-Business Development at Genentech, Inc. (1997), Director at KAI Pharmaceuticals, Inc., Director at BioMimetic Therapeutics, Inc. (2004-2013), Director at Satori Pharmaceuticals, Inc., Director at Carbylan Therapeutics, Inc., Director at Invuity, Inc., Director at Solace Pharmaceuticals, Inc., Director at Xenon Pharmaceuticals, Inc., Director-Licensing & Business Development at Purdue Pharma LP (1998-1999), Director-Biotechnology Strategy Development at The Lek (1992-1994), Managing Director & General Partner at InterWest Partners LLC (2000-2013), Director at CVRx, Inc., Director-Venture Capital at The US Russia Investment Fund (1994-1996), and Director at Follica, Inc. He was also an Independent Director at Transcept Pharma, Inc. (2009-2013) and Senior MD & Head-Global Biopharma at Locust Walk Partners LLC (2013-2021).
Mr. Ehrlich's education includes an undergraduate degree from Dartmouth College (1992) and an MBA from Kellogg School of Management (1998).
Mr. Ehrlich is also the founder of AlgoRx Pharmaceuticals, Inc...

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
3.24%
05/04/2024 482 425 ( 3.24% ) 1 M $ 31/03/2024
29/02/2024 1 409 ( 0.04% ) 20 276 $ 31/03/2024

Cargos activos de Christopher Ehrlich

EmpresasCargoInicio
EFFECTOR THERAPEUTICS, INC. Director/Board Member 25/08/2021
Director/Board Member 20/09/2022
Founder 01/01/2014
Director/Board Member 01/10/2004
Todos los cargos activos de Christopher Ehrlich

Antiguos cargos conocidos de Christopher Ehrlich.

EmpresasCargoFin
EFFECTOR THERAPEUTICS, INC. Chief Executive Officer 01/08/2021
Corporate Officer/Principal 01/01/2021
INVUITY INC Director/Board Member 01/01/2018
Director/Board Member 31/12/2013
Corporate Officer/Principal 01/01/2013
Ver el detalle de la experiencia de Christopher Ehrlich.

Formación de Christopher Ehrlich.

Dartmouth College Undergraduate Degree
Kellogg School of Management Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Christopher Ehrlich.

Relaciones

99

Relaciones de 1er grado

25

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
XENON PHARMACEUTICALS INC.

Health Technology

CVRX, INC.

Health Technology

EFFECTOR THERAPEUTICS, INC.

Health Technology

Empresas privadas20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Finance

Consumer Services

Health Technology

Commercial Services

Commercial Services

Finance

Finance

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Christopher Ehrlich